A medical device from Medtronic (NYSE: MDT) aimed at fixing hard-to-treat high blood pressure — potentially a big new market for the med-tech company — proved effective in a new trial, years after yielding disappointing results in an initial study.
The Wall Street Journal reports on results of the Medtronic Symplicity Spyral, which is designed to offer a minimally invasive alternative to medications to help treat hypertension in patients. The device works by using radio-frequency waves to calm…
